The results of analysis revealed significant upregulation of gene sets associated with p38 MAPK activation, p53 activation, and cellular senescence across all craniosynostosis-derived human and murine samples compared to controls (Figs. 6a–d, S6a and S6b). The gene discussed is TP53; the disease is craniosynostosis.